Search results
Alumni Achievement Awards 2000: Gordon M. Binder Initiatives focus on societal challenges that are too complex for any one discipline or industry to solve alone. ǁ
Mr. Gordon Binder is the Chairman of the Board of Directors of NEUVOGEN. He was Chief Executive Officer of Amgen, Inc. the world’s largest biotech company, from 1988 through 2000. During Mr. Binder’s tenure as CEO, the company grew from 400 employees to 7,000 to rank within the top 20 pharmaceutical companies in worldwide revenues, the top ...
Gordon M. Binder is Board of Directors at American Enterprise Institute.
Gordon and Adele Binder. SOURCE OF WEALTH: Coastview Capital, Amgen. FUNDING AREAS: Education & Youth, Policy, Arts & Culture, Health & Human Services, Jewish Causes.
He is the Founder and Managing Director of Coastview Capital, a private investment firm. [1] [3] [5] He also serves as Chairman of SRU Biosystems. [6] He sits on the Boards of Directors of Acadia Pharmaceuticals , Cellular Genomics, PhRMA and the Biotechnology Industry Organization .
Find company research, competitor information, contact details & financial data for Coastview Capital Llc of Pasadena, CA. Get the latest business insights from Dun & Bradstreet.
3 mar 2002 · Almost a year after starting a local biomedical venture capital firm, retired Amgen Inc. Chairman Gordon Binder is close to raising his first fund, which is set at $100 million, sources say.
